Navigating Myelofibrosis-Associated Anemia Together: Empowering Collaboration and Communication Authors: Francesco Passamonti, MD

https://www.medscape.org/viewarticle/navigating-myelofibrosis-associated-anemia-together-2026a10007ks?page=1&src=mkmcmr_driv_stan_mscpedu_260805-OUS-HONC-navigating-myelofibrosis-associated-anemia-together-2026a10007ks-cta&uac=148436CN

Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial Prof Rohit Loomba, MDa Send email to roloomba@health.ucsd.edu ∙ Prof Jacob George, MBBSb ∙ Prof Laurent Castera, MDc,d ∙ Prof Sven Francque, MDe ∙ Prof Eric Lawitz, MDf ∙ Ahsan Shoeb, MDg ∙ et al.

Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial Prof Rohit Loomba, MDa Send email to roloomba@health.ucsd.edu ∙ Prof Jacob George, MBBSb ∙ Prof Laurent Castera, MDc,d ∙ Prof Sven Francque, MDe ∙ Prof Eric Lawitz, MDf ∙ Ahsan Shoeb, MDg ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00123-8/fulltext?dgcid=raven_jbs_etoc_feature_langas

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial Prof John Burn, MDa,b Send email to john.burn@newcastle.ac.uk ∙ Dr Gillian M Borthwick, PhDa ∙ Faye Elliott, MScc ∙ Prof Finlay Macrae, MBBSd ∙ Kai Ren Ong, MDe ∙ Alison C Kraus, MDf ∙ et al.

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial Prof John Burn, MDa,b Send email to john.burn@newcastle.ac.uk ∙ Dr Gillian M Borthwick, PhDa ∙ Faye Elliott, MScc ∙ Prof Finlay Macrae, MBBSd ∙ Kai Ren Ong, MDe ∙ Alison C Kraus, MDf ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00114-7/fulltext?dgcid=raven_jbs_etoc_feature_langas

A decade in gastroenterology and hepatology The Lancet Gastroenterology & Hepatology +...

A decade in gastroenterology and hepatology The Lancet Gastroenterology & Hepatology https://www.thelancet.com/journals/langas/issue/vol11no9/PIIS2468-1253(26)X2007-6

Women's health in times of war The Lancet Obstetrics, Gynaecology, & Women's Health +...

Women's health in times of war The Lancet Obstetrics, Gynaecology, & Women's Health https://www.thelancet.com/journals/lanogw/issue/vol2no8/PIIS3050-5038(26)X2007-6

Managing Endometrial Cancer: Unpacking the Data Behind the Latest Immunotherapy Advancements Authors: Ana Oaknin, MD, PhD; Domenica Lorusso, MD, PhD

https://www.medscape.org/viewarticle/managing-endometrial-cancer-unpacking-data-behind-latest-2026a1000bh0?page=1&uac=148436CN&src=mkmcmr_driv_cust_mscpedu_260806-OUS-HONC_NOLO-managing-endometrial-cancer-unpacking-data-behind-latest-2026a1000bh0-cta

Antibody Engineering: How Modern Antibody Technologies Are Transforming Healthcare

https://www.news-medical.net/life-sciences/Antibody-Engineering-How-Modern-Antibody-Technologies-Are-Transforming-Healthcare.aspx Antibodies are essential components of the adaptive immune system that have transformed biomedical research, diagnostics, and precision medicine through their ability to specifically recognize and target antigens. This article explores antibody structure, laboratory applications, therapeutic antibodies, antibody-drug conjugates (ADCs), bispecific antibodies, and emerging innovations that continue to advance targeted disease treatment.